{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:19:48Z","timestamp":1790662788499,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02085-8","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:37:08Z","timestamp":1771904228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u03b2-Hydroxybutyrate, a primary metabolite of ketogenic diets and its dual role in modulating colorectal cancer: from molecular mechanisms to therapeutic insights"],"prefix":"10.1007","volume":"26","author":[{"given":"Parisa","family":"Rashidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Khodayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Tarkashvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Elahirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihaneh","family":"Akhoondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr Hoseinzadeh","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Sanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Haghighatjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Mehboodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Banimahdidehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0053-6273","authenticated-orcid":false,"given":"Saman","family":"Rabiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houra","family":"Dinvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4264","authenticated-orcid":false,"given":"Mohammad Hasan","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2085_CR1","doi-asserted-by":"crossref","unstructured":"Neitzel C, Demuth P, Wittmann S, Fahrer J. Targeting altered energy metabolism in colorectal cancer: oncogenic reprogramming, the central role of the TCA cycle and therapeutic opportunities. Cancers (Basel). 2020;12(7):1731.","DOI":"10.3390\/cancers12071731"},{"issue":"8","key":"2085_CR2","doi-asserted-by":"publisher","first-page":"e147563","DOI":"10.5812\/jjm-147563","volume":"17","author":"SA Hosseininasab","year":"2024","unstructured":"Hosseininasab SA, Saffari F, Tadjrobehkar O, Zandi H, Ahmadi B, Khoshnood A, et al. Diffusely adherent and Cyclomodulin-Positive Escherichia coli are associated with colon diseases. Jundishapur J Microbiol. 2024;17(8):e147563.","journal-title":"Jundishapur J Microbiol"},{"issue":"1","key":"2085_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15(1):160.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"2085_CR4","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-23-2742","volume":"84","author":"S Murphy","year":"2024","unstructured":"Murphy S, Rahmy S, Gan D, Liu G, Zhu Y, Manyak M, et al. Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to overcome resistance to immune checkpoint Blockade therapy. Cancer Res. 2024;84(10):1597\u2013612.","journal-title":"Cancer Res"},{"key":"2085_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E. beta-Hydroxybutyrate: A signaling metabolite. Annu Rev Nutr. 2017;37:51\u201376.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"2085_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s11033-024-09754-5","volume":"51","author":"MH Maleki","year":"2024","unstructured":"Maleki MH, Omidi F, Javanshir Z, Bagheri M, Tanhadoroodzani Z, Dastghaib S, et al. beta-Hydroxybutyrate and melatonin suppress maladaptive UPR, excessive autophagy and pyroptosis in Abeta 1\u201342 and LPS-Induced SH-SY5Y cells. Mol Biol Rep. 2024;51(1):802.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2085_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11033-024-09355-2","volume":"51","author":"N Mohammadipoor","year":"2024","unstructured":"Mohammadipoor N, Naiebi R, Mazhari SA, Amooei F, Owrang M, Dastghaib S, et al. Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and Quercetin target hypoxia-induced angiogenesis and multidrug resistance. Mol Biol Rep. 2024;51(1):379.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2085_CR8","first-page":"8805868","volume":"2024","author":"R Rezaei","year":"2024","unstructured":"Rezaei R, Abdali Larki A, Hosseinzadegan R, Dashti Z, Tarkashvand S, Akhoondi R, et al. Exploring the therapeutic potential of \u03b2-Hydroxybutyrate (BHB) in clear cell renal cell carcinoma: A journey into fat Browning, Autophagy, and tumor slimming. Int J Clin Pract. 2024;2024(1):8805868.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2085_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11033-023-08977-2","volume":"51","author":"F Roohy","year":"2024","unstructured":"Roohy F, Siri M, Kohansal K, Ghalandari A, Rezaei R, Maleki MH, et al. Targeting apoptosis and unfolded protein response: the impact of \u03b2-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions. Mol Biol Rep. 2024;51(1):168.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"2085_CR10","first-page":"e00038","volume":"2","author":"J Yang","year":"2023","unstructured":"Yang J, Zhang N, Wang Z, Wang Q, Han J, Khan MA, et al. \u03b2-hydroxybutyrate inhibits cellular proliferation, EMT, stemness, migration, and invasion in glioma cells. Precision Nutr. 2023;2(2):e00038.","journal-title":"Precision Nutr"},{"issue":"3","key":"2085_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s13273-023-00378-7","volume":"20","author":"J Huang","year":"2024","unstructured":"Huang J, Chen X, Lin H, Chen X. \u03b2-Hydroxybutyrate impairs nasopharyngeal carcinoma cell aggressiveness via histone deacetylase 4 Inhibition. Mol Cell Toxicol. 2024;20(3):629\u201340.","journal-title":"Mol Cell Toxicol"},{"issue":"1","key":"2085_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41421-023-00636-x","volume":"10","author":"Y-N Qiao","year":"2024","unstructured":"Qiao Y-N, Li L, Hu S-H, Yang Y-X, Ma Z-Z, Huang L, et al. Ketogenic diet-produced \u03b2-hydroxybutyric acid accumulates brain GABA and increases GABA\/glutamate ratio to inhibit epilepsy. Cell Discovery. 2024;10(1):17.","journal-title":"Cell Discovery"},{"issue":"23","key":"2085_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/s41388-023-02700-y","volume":"42","author":"T Mao","year":"2023","unstructured":"Mao T, Qin F, Zhang M, Li J, Li J, Lai M. Elevated serum beta-hydroxybutyrate, a Circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1. Oncogene. 2023;42(23):1889\u201399.","journal-title":"Oncogene"},{"issue":"2","key":"2085_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tem.2023.10.002","volume":"35","author":"PMM Ruppert","year":"2024","unstructured":"Ruppert PMM, Kersten S. Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting. Trends Endocrinol Metab. 2024;35(2):107\u201324.","journal-title":"Trends Endocrinol Metab"},{"key":"2085_CR15","unstructured":"Kuykendall NS, Kuykendall JR. Ketones in the Life Sciences\u2013Biochemistry, Metabolism, and Medicinal Significances. 2024."},{"key":"2085_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","volume":"41","author":"P Puchalska","year":"2021","unstructured":"Puchalska P, Crawford PA. Metabolic and signaling roles of ketone bodies in health and disease. Annu Rev Nutr. 2021;41:49\u201377.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"2085_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ijms25010124","volume":"25","author":"J Jang","year":"2024","unstructured":"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, et al. Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases. Int J Mol Sci. 2024;25(1):124.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2085_CR18","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.jbc.2022.102838","volume":"299","author":"PK Arnold","year":"2023","unstructured":"Arnold PK, Finley LWS. Regulation and function of the mammalian Tricarboxylic acid cycle. J Biol Chem. 2023;299(2):102838.","journal-title":"J Biol Chem"},{"key":"2085_CR19","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.molmet.2024.101934","volume":"84","author":"R Hatano","year":"2024","unstructured":"Hatano R, Lee E, Sato H, Kiuchi M, Hirahara K, Nakagawa Y, et al. Hepatic ketone body regulation of renal gluconeogenesis. Mol Metab. 2024;84:101934.","journal-title":"Mol Metab"},{"issue":"1","key":"2085_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11033-024-09501-w","volume":"51","author":"FI Shirian","year":"2024","unstructured":"Shirian FI, Karimi M, Alipour M, Salami S, Nourbakhsh M, Nekufar S, et al. Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition. Mol Biol Rep. 2024;51(1):567.","journal-title":"Mol Biol Rep"},{"issue":"22","key":"2085_CR21","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.3390\/nu14224932","volume":"14","author":"CY Hwang","year":"2022","unstructured":"Hwang CY, Choe W, Yoon KS, Ha J, Kim SS, Yeo EJ, Kang I. Molecular mechanisms for ketone body Metabolism, signaling Functions, and therapeutic potential in cancer. Nutrients. 2022;14(22):4932.","journal-title":"Nutrients"},{"issue":"1","key":"2085_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40170-024-00339-1","volume":"12","author":"H Fulman-Levy","year":"2024","unstructured":"Fulman-Levy H, Cohen-Harazi R, Levi B, Argaev-Frenkel L, Abramovich I, Gottlieb E, et al. Metabolic alterations and cellular responses to beta-Hydroxybutyrate treatment in breast cancer cells. Cancer Metab. 2024;12(1):16.","journal-title":"Cancer Metab"},{"issue":"11","key":"2085_CR23","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.31557\/APJCP.2018.19.11.3287","volume":"19","author":"A Shakery","year":"2018","unstructured":"Shakery A, Pourvali K, Ghorbani A, Fereidani SS, Zand H. Beta-Hydroxybutyrate promotes Proliferation, migration and stemness in a subpopulation of 5FU treated SW480 cells: evidence for metabolic plasticity in colon cancer. Asian Pac J Cancer Prev. 2018;19(11):3287\u201394.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2085_CR24","doi-asserted-by":"crossref","unstructured":"Urz\u00ec AG, Tropea E, Gattuso G, Spoto G, Marsala G, Calina D, et al. Ketogenic diet and breast cancer: recent findings and therapeutic approaches. Nutrients. 2023;15(20):4357.","DOI":"10.3390\/nu15204357"},{"key":"2085_CR25","doi-asserted-by":"crossref","unstructured":"Tamraz M, Al Ghossaini N, Temraz S. The ketogenic diet in colorectal cancer: A means to an end. Int J Mol Sci. 2023;24(4):3683.","DOI":"10.3390\/ijms24043683"},{"issue":"23","key":"2085_CR26","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/s41388-023-02700-y","volume":"42","author":"T Mao","year":"2023","unstructured":"Mao T, Qin F, Zhang M, Li J, Li J, Lai M. Elevated serum \u03b2-hydroxybutyrate, a Circulating ketone metabolite, accelerates colorectal cancer proliferation and metastasis via ACAT1. Oncogene. 2023;42(23):1889\u201399.","journal-title":"Oncogene"},{"issue":"12","key":"2085_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1089\/dna.2022.0486","volume":"41","author":"S Khoziainova","year":"2022","unstructured":"Khoziainova S, Rozenberg G, Levy M. Ketogenic diet and Beta-Hydroxybutyrate in colorectal cancer. DNA Cell Biol. 2022;41(12):1007\u201311.","journal-title":"DNA Cell Biol"},{"key":"2085_CR28","doi-asserted-by":"publisher","first-page":"1202186","DOI":"10.3389\/fphys.2023.1202186","volume":"14","author":"KL Storoschuk","year":"2023","unstructured":"Storoschuk KL, Wood TR, Stubbs BJ. A systematic review and meta-regression of exogenous ketone infusion rates and resulting ketosis-A tool for clinicians and researchers. Front Physiol. 2023;14:1202186.","journal-title":"Front Physiol"},{"issue":"16\u201317","key":"2085_CR29","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1007\/s00253-021-11482-w","volume":"105","author":"A Yao","year":"2021","unstructured":"Yao A, Li Z, Lyu J, Yu L, Wei S, Xue L, et al. On the nutritional and therapeutic effects of ketone body D-beta-hydroxybutyrate. Appl Microbiol Biotechnol. 2021;105(16\u201317):6229\u201343.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"2085_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1113\/EP090430","volume":"108","author":"K Falkenhain","year":"2023","unstructured":"Falkenhain K, Islam H, Little JP. Exogenous ketone supplementation: an emerging tool for physiologists with potential as a metabolic therapy. Exp Physiol. 2023;108(2):177\u201387.","journal-title":"Exp Physiol"},{"issue":"Suppl 1","key":"2085_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40279-022-01756-2","volume":"52","author":"M Evans","year":"2022","unstructured":"Evans M, McClure TS, Koutnik AP, Egan B. Exogenous ketone supplements in athletic contexts: Past, Present, and future. Sports Med. 2022;52(Suppl 1):25\u201367.","journal-title":"Sports Med"},{"issue":"5","key":"2085_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","volume":"2","author":"GD Lopaschuk","year":"2023","unstructured":"Lopaschuk GD, Dyck JRB. Ketones and the cardiovascular system. Nat Cardiovasc Res. 2023;2(5):425\u201337.","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"2085_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/ijms22020524","volume":"22","author":"L Suissa","year":"2021","unstructured":"Suissa L, Kotchetkov P, Guigonis JM, Doche E, Osman O, Pourcher T, Lindenthal S. Ingested ketone ester leads to a rapid rise of Acetyl-CoA and competes with glucose metabolism in the brain of Non-Fasted mice. Int J Mol Sci. 2021;22(2):524.","journal-title":"Int J Mol Sci"},{"key":"2085_CR34","doi-asserted-by":"publisher","first-page":"947567","DOI":"10.3389\/fnut.2022.947567","volume":"9","author":"CGJ Saris","year":"2022","unstructured":"Saris CGJ, Timmers S. Ketogenic diets and ketone suplementation: A strategy for therapeutic intervention. Front Nutr. 2022;9:947567.","journal-title":"Front Nutr"},{"key":"2085_CR35","unstructured":"Rumano M, Rumano E, Metani B, Joti J. Calorie restriction and fasting effect on human health. J Hyg Eng Des. 2023;45:252\u2011262."},{"issue":"7","key":"2085_CR36","first-page":"787","volume":"14","author":"M Breuling","year":"2024","unstructured":"Breuling M, Tomeva E, Ivanovic N, Haslberger A. Butyrate- and Beta-Hydroxybutyrate-Mediated effects of interventions with Pro- and Prebiotics, Fasting, and caloric restrictions on depression: A systematic review and Meta-Analysis. Life (Basel). 2024;14(7):787.","journal-title":"Life (Basel)"},{"issue":"6","key":"2085_CR37","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/nu14061166","volume":"14","author":"A Giacco","year":"2022","unstructured":"Giacco A, Cioffi F, Cuomo A, Simiele R, Senese R, Silvestri E, et al. Mild endurance exercise during fasting increases gastrocnemius muscle and prefrontal cortex thyroid hormone levels through differential BHB and BCAA-mediated BDNF-mTOR signaling in rats. Nutrients. 2022;14(6):1166.","journal-title":"Nutrients"},{"key":"2085_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clnesp.2023.01.030","volume":"54","author":"A Buga","year":"2023","unstructured":"Buga A, Kackley ML, Crabtree CD, Bedell TN, Robinson BT, Stoner JT, et al. Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R\/S-BHB salts. Clin Nutr ESPEN. 2023;54:277\u201387.","journal-title":"Clin Nutr ESPEN"},{"issue":"12","key":"2085_CR39","doi-asserted-by":"publisher","first-page":"102648","DOI":"10.1016\/j.jbc.2022.102648","volume":"298","author":"ES Selen","year":"2022","unstructured":"Selen ES, Rodriguez S, Cavagnini KS, Kim HB, Na CH, Wolfgang MJ. Requirement of hepatic pyruvate carboxylase during fasting, high fat, and ketogenic diet. J Biol Chem. 2022;298(12):102648.","journal-title":"J Biol Chem"},{"key":"2085_CR40","doi-asserted-by":"crossref","unstructured":"Alfaro AJ, Herzig S. Fasting-regulated mechanisms in inter-organ crosstalk. Curr Opin Endocr Metabolic Res. 2024;36(12):100540.","DOI":"10.1016\/j.coemr.2024.100540"},{"issue":"3","key":"2085_CR41","doi-asserted-by":"publisher","first-page":"e1389","DOI":"10.1210\/clinem\/dgaa707","volume":"106","author":"B Liu","year":"2021","unstructured":"Liu B, Hutchison AT, Thompson CH, Lange K, Wittert GA, Heilbronn LK. Effects of intermittent fasting or calorie restriction on markers of lipid metabolism in human skeletal muscle. J Clin Endocrinol Metab. 2021;106(3):e1389\u201399.","journal-title":"J Clin Endocrinol Metab"},{"key":"2085_CR42","doi-asserted-by":"crossref","unstructured":"Alidadi M, Banach M, Guest PC, Bo S, Jamialahmadi T, Sahebkar A, editors. The effect of caloric restriction and fasting on cancer. Seminars in Cancer Biology; 2021: Elsevier.","DOI":"10.1016\/j.semcancer.2020.09.010"},{"issue":"5","key":"2085_CR43","first-page":"2299","volume":"29","author":"EM Ibrahim","year":"2021","unstructured":"Ibrahim EM, Al-Foheidi MH, Al-Mansour MM. Energy and caloric restriction, and fasting and cancer: a narrative review. Support Care Cancer. 2021;29(5):2299\u2013304.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2085_CR44","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/jcm12041589","volume":"12","author":"M Israel","year":"2023","unstructured":"Israel M, Berg E, Tenenbaum G. Cancer metabolism: fasting Reset, the Keto-Paradox and drugs for undoing. J Clin Med. 2023;12(4):1589.","journal-title":"J Clin Med"},{"issue":"5","key":"2085_CR45","first-page":"2","volume":"176","author":"E Berg","year":"2023","unstructured":"Berg E, Tenenbaum G, Israel M. Unraveling the cancer metabolism: fasting Reset, ketogenic Diet, and therapeutic strategies. J Cancer Res Reviews. 2023;176(5):2\u20137. & Reports SRC\/JCRR-186 DOI: doi org\/1047363\/JCRR\/2023","journal-title":"J Cancer Res Reviews"},{"issue":"10","key":"2085_CR46","doi-asserted-by":"publisher","first-page":"107839","DOI":"10.1016\/j.isci.2023.107839","volume":"26","author":"MP Udumula","year":"2023","unstructured":"Udumula MP, Singh H, Rashid F, Poisson L, Tiwari N, Dimitrova I, et al. Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response. iScience. 2023;26(10):107839.","journal-title":"iScience"},{"issue":"1","key":"2085_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33425\/2996-3893.1007","volume":"2","author":"A Udristioiu","year":"2024","unstructured":"Udristioiu A, Cojocaru M, Martin L. Relationship between restrictive diet and autophagy in preventing cancer cells. Trends Gen Med. 2024;2(1):1\u201310.","journal-title":"Trends Gen Med"},{"issue":"8","key":"2085_CR48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/metabo14080418","volume":"14","author":"UE De-Leon-Covarrubias","year":"2024","unstructured":"De-Leon-Covarrubias UE, Perez-Trujillo JJ, Villa-Cedillo SA, Martinez-Perez AG, Montes-de-Oca-Saucedo CR, Loera-Arias MJ, et al. Unlocking the potential: caloric restriction, caloric restriction mimetics, and their impact on cancer prevention and treatment. Metabolites. 2024;14(8):418.","journal-title":"Metabolites"},{"issue":"5","key":"2085_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.24018\/clinicmed.2024.5.5.345","volume":"5","author":"ACM do R\u00eago","year":"2024","unstructured":"do R\u00eago ACM, Ara\u00fajo-Filho I. Intermittent fasting on cancer: an update. Eur J Clin Med. 2024;5(5):22\u20137.","journal-title":"Eur J Clin Med"},{"key":"2085_CR50","first-page":"26","volume":"30","author":"C Crespo-Garcia","year":"2024","unstructured":"Crespo-Garcia C, Campbell JP, Taaffe DR, Peddle-McIntyre CJ, Jeffery E, Galvao DA, et al. Unleashing anti-tumour immunity: dietary restriction and exercise interventions adjunct to chemotherapy for cancer patients. Exerc Immunol Rev. 2024;30:26\u201348.","journal-title":"Exerc Immunol Rev"},{"issue":"1","key":"2085_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.34701","volume":"154","author":"F Ligorio","year":"2024","unstructured":"Ligorio F, Lobefaro R, Fuc\u00e0 G, Provenzano L, Zanenga L, Nasca V, et al. Adding fasting-mimicking diet to first\u2010line carboplatin\u2010based chemotherapy is associated with better overall survival in advanced triple\u2010negative breast cancer patients: A subanalysis of the NCT03340935 trial. Int J Cancer. 2024;154(1):114\u201323.","journal-title":"Int J Cancer"},{"key":"2085_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fendo.2016.00005","volume":"7","author":"MM Grabacka","year":"2016","unstructured":"Grabacka MM, Wilk A, Antonczyk A, Banks P, Walczyk-Tytko E, Dean M, et al. Fenofibrate induces ketone body production in melanoma and glioblastoma cells. Front Endocrinol (Lausanne). 2016;7:5.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2085_CR53","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fncel.2019.00172","volume":"13","author":"JM Rho","year":"2019","unstructured":"Rho JM, Shao LR, Stafstrom CE. 2-Deoxyglucose and Beta-Hydroxybutyrate: metabolic agents for seizure control. Front Cell Neurosci. 2019;13:172.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2085_CR54","first-page":"6663782","volume":"2021","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W, Bao W, Lu J. Fenofibrate exerts antitumor effects in colon cancer via regulation of DNMT1 and CDKN2A. PPAR Res. 2021;2021(1):6663782.","journal-title":"PPAR Res"},{"issue":"3","key":"2085_CR55","doi-asserted-by":"publisher","first-page":"e0151115","DOI":"10.1371\/journal.pone.0151115","volume":"11","author":"D Zhang","year":"2016","unstructured":"Zhang D, Fei Q, Li J, Zhang C, Sun Y, Zhu C, et al. 2-Deoxyglucose reverses the promoting effect of insulin on colorectal cancer cells in vitro. PLoS ONE. 2016;11(3):e0151115.","journal-title":"PLoS ONE"},{"issue":"1","key":"2085_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13578-023-00977-w","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zou S, Fang L. Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. Cell Biosci. 2023;13(1):25.","journal-title":"Cell Biosci"},{"key":"2085_CR57","doi-asserted-by":"publisher","first-page":"698951","DOI":"10.3389\/fonc.2021.698951","volume":"11","author":"L Reinsalu","year":"2021","unstructured":"Reinsalu L, Puurand M, Chekulayev V, Miller S, Shevchuk I, Tepp K, et al. Energy metabolic plasticity of colorectal cancer cells as a determinant of tumor growth and metastasis. Front Oncol. 2021;11:698951.","journal-title":"Front Oncol"},{"issue":"1","key":"2085_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcb.30347","volume":"124","author":"D Chen","year":"2023","unstructured":"Chen D, Zhou X, Yan P, Yang C, Li Y, Han L, Ren X. Lipid metabolism reprogramming in colorectal cancer. J Cell Biochem. 2023;124(1):3\u201316.","journal-title":"J Cell Biochem"},{"issue":"9","key":"2085_CR59","doi-asserted-by":"publisher","first-page":"e30212","DOI":"10.1016\/j.heliyon.2024.e30212","volume":"10","author":"M Vargas-Lopez","year":"2024","unstructured":"Vargas-Lopez M, Quiroz-Vicente CA, Perez-Hernandez N, Gomez-Chavez F, Banuelos-Hernandez AE, Perez-Hernandez E. The ketone body beta-Hydroxybutyrate as a fuel source of chondrosarcoma cells. Heliyon. 2024;10(9):e30212.","journal-title":"Heliyon"},{"issue":"10","key":"2085_CR60","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00384-011-1238-0","volume":"26","author":"MP Macedo","year":"2011","unstructured":"Macedo MP, Andrade Lde B, Coudry R, Crespo R, Gomes M, Lisboa BC, et al. Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports. Int J Colorectal Dis. 2011;26(10):1241\u20138.","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"2085_CR61","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.3390\/ijms131012153","volume":"13","author":"AK Arrington","year":"2012","unstructured":"Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, et al. Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci. 2012;13(10):12153\u201368.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2085_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1309\/AJCP7FO2VAXIVSTP","volume":"135","author":"X Liu","year":"2011","unstructured":"Liu X, Jakubowski M, Hunt JL. KRAS gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis. Am J Clin Pathol. 2011;135(2):245\u201352.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2085_CR63","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/CAD.0000000000000175","volume":"26","author":"L Teimoori-Toolabi","year":"2015","unstructured":"Teimoori-Toolabi L, Hashemi S, Azadmanesh K, Eghbalpour F, Safavifar F, Khorramizadeh MR. Silencing the wild-type and mutant K-ras increases the resistance to 5-flurouracil in HCT-116 as a colorectal cancer cell line. Anticancer Drugs. 2015;26(2):187\u201396.","journal-title":"Anticancer Drugs"},{"issue":"8","key":"2085_CR64","doi-asserted-by":"publisher","first-page":"e70604","DOI":"10.1371\/journal.pone.0070604","volume":"8","author":"C Luu","year":"2013","unstructured":"Luu C, Heinrich EL, Duldulao M, Arrington AK, Fakih M, Garcia-Aguilar J, Kim J. TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. PLoS ONE. 2013;8(8):e70604.","journal-title":"PLoS ONE"},{"key":"2085_CR65","doi-asserted-by":"publisher","first-page":"100824","DOI":"10.1016\/j.genrep.2020.100824","volume":"21","author":"S Malmir","year":"2020","unstructured":"Malmir S, Ebrahimi A, Mahjoubi F. Effect of ginger extracts on colorectal cancer HCT-116 cell line in the expression of MMP-2 and KRAS. Gene Rep. 2020;21:100824.","journal-title":"Gene Rep"},{"issue":"2","key":"2085_CR66","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/1078-0432.CCR-15-0829","volume":"22","author":"EK Ziemke","year":"2016","unstructured":"Ziemke EK, Dosch JS, Maust JD, Shettigar A, Sen A, Welling TH, et al. Sensitivity of KRAS-Mutant colorectal cancers to combination therapy that cotargets MEK and CDK4\/6. Clin Cancer Res. 2016;22(2):405\u201314.","journal-title":"Clin Cancer Res"},{"key":"2085_CR67","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopha.2018.04.099","volume":"103","author":"JJ Mou","year":"2018","unstructured":"Mou JJ, Peng J, Shi YY, Li N, Wang Y, Ke Y, et al. Mitochondrial DNA content reduction induces aerobic Glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells. Biomed Pharmacother. 2018;103:729\u201337.","journal-title":"Biomed Pharmacother"},{"issue":"176","key":"2085_CR68","doi-asserted-by":"publisher","first-page":"361","DOI":"10.24976\/Discov.Med.202335176.37","volume":"35","author":"Y Gao","year":"2023","unstructured":"Gao Y, Wang Y, Wang X, Ma J, Wei M, Li N, Zhao Z. FABP4 regulates cell Proliferation, Stemness, Apoptosis, and Glycolysis in colorectal cancer via modulating ROS\/ERK\/mTOR pathway. Discov Med. 2023;35(176):361\u201371.","journal-title":"Discov Med"},{"key":"2085_CR69","doi-asserted-by":"publisher","first-page":"154518","DOI":"10.1016\/j.prp.2023.154518","volume":"247","author":"JP Steeghs","year":"2023","unstructured":"Steeghs JP, Offermans K, Jenniskens JC, Samarska I, Fazzi GE, van den Brandt PA, Grabsch HI. Relationship between the Warburg effect in tumour cells and the tumour microenvironment in colorectal cancer patients: results from a large multicentre study. Pathology-Research Pract. 2023;247:154518.","journal-title":"Pathology-Research Pract"},{"key":"2085_CR70","doi-asserted-by":"publisher","first-page":"588811","DOI":"10.3389\/fonc.2021.588811","volume":"11","author":"J Zhu","year":"2021","unstructured":"Zhu J, Wang S, Bai H, Wang K, Hao J, Zhang J, Li J. Identification of five Glycolysis-Related gene signature and risk score model for colorectal cancer. Front Oncol. 2021;11:588811.","journal-title":"Front Oncol"},{"key":"2085_CR71","doi-asserted-by":"publisher","first-page":"175856","DOI":"10.1016\/j.ejphar.2023.175856","volume":"954","author":"F Chen","year":"2023","unstructured":"Chen F, Liao J, Wu P, Cheng L, Ma Y, Zhang L, et al. Oridonin inhibits the occurrence and development of colorectal cancer by reversing the Warburg effect via reducing PKM2 dimer formation and preventing its entry into the nucleus. Eur J Pharmacol. 2023;954:175856.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2085_CR72","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1080\/15548627.2019.1687213","volume":"16","author":"K Qureshi-Baig","year":"2020","unstructured":"Qureshi-Baig K, Kuhn D, Viry E, Pozdeev VI, Schmitz M, Rodriguez F, et al. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC\/PKC-EZR (ezrin) pathway. Autophagy. 2020;16(8):1436\u201352.","journal-title":"Autophagy"},{"issue":"1","key":"2085_CR73","doi-asserted-by":"publisher","first-page":"112175","DOI":"10.1016\/j.yexcr.2020.112175","volume":"395","author":"M Deng","year":"2020","unstructured":"Deng M, Zhang W, Yuan L, Tan J, Chen Z. HIF-1a regulates hypoxia-induced autophagy via translocation of ANKRD37 in colon cancer. Exp Cell Res. 2020;395(1):112175.","journal-title":"Exp Cell Res"},{"key":"2085_CR74","doi-asserted-by":"publisher","first-page":"566430","DOI":"10.3389\/fonc.2020.566430","volume":"10","author":"L Qi","year":"2020","unstructured":"Qi L, Chen J, Yang Y, Hu W. Hypoxia correlates with poor survival and M2 macrophage infiltration in colorectal cancer. Front Oncol. 2020;10:566430.","journal-title":"Front Oncol"},{"issue":"1","key":"2085_CR75","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"issue":"1","key":"2085_CR76","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12967-024-05391-5","volume":"22","author":"A Huang","year":"2024","unstructured":"Huang A, Sun Z, Hong H, Yang Y, Chen J, Gao Z, Gu J. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. J Transl Med. 2024;22(1):587.","journal-title":"J Transl Med"},{"issue":"3","key":"2085_CR77","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/antiox12030683","volume":"12","author":"M Spada","year":"2023","unstructured":"Spada M, Piras C, Diana G, Leoni VP, Frau DV, Serreli G, et al. Glutamine starvation affects cell Cycle, oxidative homeostasis and metabolism in colorectal cancer cells. Antioxid (Basel). 2023;12(3):683.","journal-title":"Antioxid (Basel)"},{"key":"2085_CR78","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.tranon.2024.102078","volume":"48","author":"AEG Ta\u015fk\u0131ran","year":"2024","unstructured":"Ta\u015fk\u0131ran AEG, Karao\u011flu DA, Eylem CC, Ermi\u015f \u00c7, G\u00fcderer \u0130, Nemutlu E, et al. Glutamine withdrawal leads to the Preferential activation of lipid metabolism in metastatic colorectal cancer. Translational Oncol. 2024;48:102078.","journal-title":"Translational Oncol"},{"key":"2085_CR79","doi-asserted-by":"publisher","first-page":"175655","DOI":"10.1016\/j.ejphar.2023.175655","volume":"949","author":"M Samec","year":"2023","unstructured":"Samec M, Mazurakova A, Lucansky V, Koklesova L, Pecova R, Pec M, et al. Flavonoids attenuate cancer metabolism by modulating lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. Eur J Pharmacol. 2023;949:175655.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2085_CR80","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-022-01113-9","volume":"7","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, Wang M, Miao H. Ketogenic diet: new avenues to overcome colorectal cancer. Signal Transduct Target Ther. 2022;7(1):262.","journal-title":"Signal Transduct Target Ther"},{"key":"2085_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26685\/urncst.223","volume":"5","author":"M Shirdarreh","year":"2021","unstructured":"Shirdarreh M, Sadeghi Y, Rahimi T. The impact of ketogenic diet on colorectal cancer progression and the co-evolution of gut microbiota: a research protocol. Undergrad Res Nat Clin Sci Technol J. 2021;5:1\u20136.","journal-title":"Undergrad Res Nat Clin Sci Technol J"},{"issue":"3","key":"2085_CR82","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1053\/j.gastro.2022.06.046","volume":"163","author":"DJ Pinato","year":"2022","unstructured":"Pinato DJ. Ketogenic diet as a chemopreventative and therapeutic strategy for colon cancer. Gastroenterology. 2022;163(3):776\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"2085_CR83","doi-asserted-by":"publisher","first-page":"189063","DOI":"10.1016\/j.bbcan.2023.189063","volume":"1879","author":"A Mishra","year":"2024","unstructured":"Mishra A, Giuliani G, Longo VD. Nutrition and dietary restrictions in cancer prevention. Biochim Biophys Acta Rev Cancer. 2024;1879(1):189063.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"2085_CR84","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.3390\/ijms24065141","volume":"24","author":"A Silva","year":"2023","unstructured":"Silva A, Cerqueira MC, Rosa B, Sobral C, Pinto-Ribeiro F, Costa MF, et al. Prognostic value of monocarboxylate transporter 1 overexpression in cancer: A systematic review. Int J Mol Sci. 2023;24(6):5141.","journal-title":"Int J Mol Sci"},{"issue":"28","key":"2085_CR85","doi-asserted-by":"publisher","first-page":"e2301871","DOI":"10.1002\/advs.202301871","volume":"10","author":"X She","year":"2023","unstructured":"She X, Wu Q, Rao Z, Song D, Huang C, Feng S, et al. SETDB1 methylates MCT1 promoting tumor progression by enhancing the lactate shuttle. Adv Sci (Weinh). 2023;10(28):e2301871.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"2085_CR86","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/jcmm.17700","volume":"27","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Bi X, Lian X, Niu Z. BDH1 promotes lung cancer cell proliferation and metastases by PARP1-mediated autophagy. J Cell Mol Med. 2023;27(7):939\u201349.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"2085_CR87","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/00365521.2012.660539","volume":"47","author":"W Rzeski","year":"2012","unstructured":"Rzeski W, Walczak K, Juszczak M, Langner E, Pozarowski P, Kandefer-Szerszen M, Pierzynowski SG. Alpha-ketoglutarate (AKG) inhibits proliferation of colon adenocarcinoma cells in normoxic conditions. Scand J Gastroenterol. 2012;47(5):565\u201371.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2085_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s43018-020-0035-5","volume":"1","author":"TQ Tran","year":"2020","unstructured":"Tran TQ, Hanse EA, Habowski AN, Li H, Ishak Gabra MB, Yang Y, et al. alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nat Cancer. 2020;1(3):345\u201358.","journal-title":"Nat Cancer"},{"key":"2085_CR89","doi-asserted-by":"crossref","unstructured":"Iniguez AB, Du M, Zhu M-J. Alpha-ketoglutarate for preventing and managing intestinal epithelial dysfunction. Adv Nutr. 2024;15(4):100200.","DOI":"10.1016\/j.advnut.2024.100200"},{"issue":"7","key":"2085_CR90","doi-asserted-by":"publisher","first-page":"e2000936","DOI":"10.1002\/mnfr.202000936","volume":"65","author":"Q Tian","year":"2021","unstructured":"Tian Q, Bravo Iniguez A, Sun Q, Wang H, Du M, Zhu MJ. Dietary Alpha-Ketoglutarate promotes epithelial metabolic transition and protects against DSS-Induced colitis. Mol Nutr Food Res. 2021;65(7):e2000936.","journal-title":"Mol Nutr Food Res"},{"issue":"12","key":"2085_CR91","doi-asserted-by":"publisher","first-page":"e112675","DOI":"10.15252\/embj.2022112675","volume":"42","author":"K Hu","year":"2023","unstructured":"Hu K, Ding Y, Zhu H, Jing X, He W, Yu H, Wang X. Glutamate dehydrogenase1 supports HIF-1alpha stability to promote colorectal tumorigenesis under hypoxia. EMBO J. 2023;42(12):e112675.","journal-title":"EMBO J"},{"issue":"29","key":"2085_CR92","doi-asserted-by":"publisher","first-page":"e2201992","DOI":"10.1002\/advs.202201992","volume":"9","author":"M Tang","year":"2022","unstructured":"Tang M, Xu H, Huang H, Kuang H, Wang C, Li Q, et al. Metabolism-Based molecular subtyping endows effective ketogenic therapy in p53-Mutant colon cancer. Adv Sci (Weinh). 2022;9(29):e2201992.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"2085_CR93","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/ijms24043683","volume":"24","author":"M Tamraz","year":"2023","unstructured":"Tamraz M, Al Ghossaini N, Temraz S. The ketogenic diet in colorectal cancer: a means to an end. Int J Mol Sci. 2023;24(4):3683.","journal-title":"Int J Mol Sci"},{"key":"2085_CR94","unstructured":"Xiao P, Jiang J-J, Lu Y. Research progress of ketogenic diet and colorectal cancer."},{"issue":"7","key":"2085_CR95","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41575-022-00636-4","volume":"19","author":"J Hindson","year":"2022","unstructured":"Hindson J. CRC inhibited by the ketone body beta-hydroxybutyrate. Nat Rev Gastroenterol Hepatol. 2022;19(7):416.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2085_CR96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/JN9.0000000000000014","volume":"8","author":"J-X Han","year":"2023","unstructured":"Han J-X, Liu C-F, Xu S-Q, Cao Y-L, Wang Y-L, Yao T, et al. Mechanistic associations between dietary patterns and colorectal cancer. J Nutritional Oncol. 2023;8(2):79\u201384.","journal-title":"J Nutritional Oncol"},{"issue":"7908","key":"2085_CR97","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-022-04649-6","volume":"605","author":"O Dmitrieva-Posocco","year":"2022","unstructured":"Dmitrieva-Posocco O, Wong AC, Lundgren P, Golos AM, Descamps HC, Dohnalova L, et al. beta-Hydroxybutyrate suppresses colorectal cancer. Nature. 2022;605(7908):160\u20135.","journal-title":"Nature"},{"key":"2085_CR98","doi-asserted-by":"publisher","first-page":"216940","DOI":"10.1016\/j.canlet.2024.216940","volume":"593","author":"C Huang","year":"2024","unstructured":"Huang C, Tan H, Wang J, Huang L, Liu H, Shi Y, et al. beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis. Cancer Lett. 2024;593:216940.","journal-title":"Cancer Lett"},{"issue":"1","key":"2085_CR99","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s10020-024-00864-1","volume":"30","author":"M Deng","year":"2024","unstructured":"Deng M, Yan P, Gong H, Li G, Wang J. beta-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo. Mol Med. 2024;30(1):95.","journal-title":"Mol Med"},{"issue":"1","key":"2085_CR100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12916-022-02352-x","volume":"20","author":"C Huang","year":"2022","unstructured":"Huang C, Wang J, Liu H, Huang R, Yan X, Song M, et al. Ketone body \u03b2-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway. BMC Med. 2022;20(1):148.","journal-title":"BMC Med"},{"issue":"1","key":"2085_CR101","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1038\/s41467-022-31663-z","volume":"13","author":"CC Wong","year":"2022","unstructured":"Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, et al. The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC\/KRAS-mutant colorectal cancer. Nat Commun. 2022;13(1):3971.","journal-title":"Nat Commun"},{"issue":"1","key":"2085_CR102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00005-021-00629-2","volume":"69","author":"M Siri","year":"2021","unstructured":"Siri M, Behrouj H, Dastghaib S, Zamani M, Likus W, Rezaie S, et al. Casein Kinase-1-Alpha inhibitor (D4476) sensitizes microsatellite instable colorectal cancer cells to 5-Fluorouracil via authophagy flux Inhibition. Arch Immunol Ther Exp (Warsz). 2021;69(1):26.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"11","key":"2085_CR103","doi-asserted-by":"publisher","first-page":"e21098","DOI":"10.1016\/j.heliyon.2023.e21098","volume":"9","author":"Y He","year":"2023","unstructured":"He Y, Cheng X, Zhou T, Li D, Peng J, Xu Y, Huang W. beta-Hydroxybutyrate as an epigenetic modifier: underlying mechanisms and implications. Heliyon. 2023;9(11):e21098.","journal-title":"Heliyon"},{"issue":"6","key":"2085_CR104","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1349-7006.2012.02262.x","volume":"103","author":"T Yoshie","year":"2012","unstructured":"Yoshie T, Nishiumi S, Izumi Y, Sakai A, Inoue J, Azuma T, Yoshida M. Regulation of the metabolite profile by an APC gene mutation in colorectal cancer. Cancer Sci. 2012;103(6):1010\u201321.","journal-title":"Cancer Sci"},{"key":"2085_CR105","doi-asserted-by":"publisher","first-page":"155636","DOI":"10.1016\/j.prp.2024.155636","volume":"263","author":"A Vatankhah","year":"2024","unstructured":"Vatankhah A, Moghaddam SH, Afshari S, Afshari AR, Kesharwani P, Sahebkar A. Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme. Pathol Res Pract. 2024;263:155636.","journal-title":"Pathol Res Pract"},{"issue":"null","key":"2085_CR106","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2147\/OTT.S194986","volume":"12","author":"SL Zhang","year":"2019","unstructured":"Zhang SL, Zhu HY, Zhou BY, Chu Y, Huo JR, Tan YY, Liu DL. Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK\/ERK signal pathway. Onco Targets Ther. 2019;12(null):2409\u201319.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2085_CR107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143.","journal-title":"Mol Cancer"},{"issue":"29","key":"2085_CR108","doi-asserted-by":"publisher","first-page":"2201992","DOI":"10.1002\/advs.202201992","volume":"9","author":"M Tang","year":"2022","unstructured":"Tang M, Xu H, Huang H, Kuang H, Wang C, Li Q, et al. Metabolism-Based molecular subtyping endows effective ketogenic therapy in p53-Mutant colon cancer. Adv Sci. 2022;9(29):2201992.","journal-title":"Adv Sci"},{"key":"2085_CR109","unstructured":"Eliav S. Impact of non-alcoholic fatty liver disease, gut and intrahepatic microbiota on the risk of metachronous colorectal liver metastases. Vilniaus universitetas; 2023."},{"issue":"3","key":"2085_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/rpn.2203018","volume":"2","author":"A Patel","year":"2022","unstructured":"Patel A, Houston K, Vilela A, Saadeh M, Yoo B-S, D\u2019Souza SM, Johnson DA. Role of diet in the pathogenesis of colorectal polyps and cancer. Recent Progress Nutr. 2022;2(3):1\u201312.","journal-title":"Recent Progress Nutr"},{"key":"2085_CR111","first-page":"23433","volume":"9","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu N, Zhu W, Zhang K, Si J, Bi M, et al. Protective effect of \u03b2-hydroxybutyrate on glutamate induced cell death in HT22 cells. Int J Clin Exp Med. 2016;9:23433\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"2085_CR112","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11897-024-00645-1","volume":"21","author":"D Weissman","year":"2024","unstructured":"Weissman D, Dudek J, Sequeira V, Maack C. Fabry disease: cardiac implications and molecular mechanisms. Curr Heart Fail Rep. 2024;21(2):81\u2013100.","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"2085_CR113","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/biom10030402","volume":"10","author":"P Wojcik","year":"2020","unstructured":"Wojcik P, Zarkovic N, Gegotek A, Skrzydlewska E. Involvement of metabolic lipid mediators in the regulation of apoptosis. Biomolecules. 2020;10(3):402.","journal-title":"Biomolecules"},{"issue":"1","key":"2085_CR114","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3748\/wjg.v21.i1.84","volume":"21","author":"XL Li","year":"2015","unstructured":"Li XL, Zhou J, Chen ZR, Chng WJ. P53 mutations in colorectal cancer - molecular pathogenesis and Pharmacological reactivation. World J Gastroenterol. 2015;21(1):84\u201393.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2085_CR115","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.3390\/ijms24087317","volume":"24","author":"M Collado","year":"2023","unstructured":"Collado M, Castillo M, Mu\u00f1oz de Mier GJ, de la Pinta C, Pe\u00f1a C. The diet as a modulator of tumor microenvironment in colorectal cancer patients. Int J Mol Sci. 2023;24(8):7317.","journal-title":"Int J Mol Sci"},{"key":"2085_CR116","doi-asserted-by":"publisher","first-page":"107494","DOI":"10.1016\/j.phrs.2024.107494","volume":"210","author":"X Mi","year":"2024","unstructured":"Mi X, Duan Y, Sun J, Tai Q, Yao H, Meng L, et al. The ketogenic diet modulates tumor-associated neutrophil polarization via the AMOT-YAP\/TAZ axis to inhibit colorectal cancer progression. Pharmacol Res. 2024;210:107494.","journal-title":"Pharmacol Res"},{"issue":"759","key":"2085_CR117","doi-asserted-by":"publisher","first-page":"eabj4220","DOI":"10.1126\/scisignal.abj4220","volume":"15","author":"V Low","year":"2022","unstructured":"Low V, Li Z, Blenis J. Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment. Sci Signal. 2022;15(759):eabj4220.","journal-title":"Sci Signal"},{"issue":"11","key":"2085_CR118","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.31557\/APJCP.2018.19.11.3287","volume":"19","author":"A Shakery","year":"2018","unstructured":"Shakery A, Pourvali K, Ghorbani A, Fereidani SS, Zand H. Beta-hydroxybutyrate promotes proliferation, migration and stemness in a subpopulation of 5FU treated SW480 cells: evidence for metabolic plasticity in colon cancer. Asian Pac J Cancer Prevention: APJCP. 2018;19(11):3287.","journal-title":"Asian Pac J Cancer Prevention: APJCP"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02085-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:06:31Z","timestamp":1772546791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02085-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02085-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"168"}}